{"id": "ewpfo5", "title": "Here\u2019s ya coffee", "selftext": "*Sorry it\u2019s a tad bit late, maybe I\u2019ll give you a muffin on the house later.* \n\n\n**Of note for large tech names (FB, AAPL, AMZN, GOOG)** FTC\u2019s Phillips, a GOP member, stated antitrust enforcement is not an answer to privacy concerns surrounding the tech giants, questioning if it would lead to better privacy protections for the consumers, according to WSJ.\n\n#DOW\n\n**Caterpillar Inc. (CAT)** Q4 19 (USD): EPS 2.63 (exp. 2.37), Revenue 13.14bln (exp. 13.41bln). FY EPS view 8.50-10.00 (exp. 10.63) - Expects continued global economic uncertainty to pressure sales to users in 2020 and cause dealers to further reduce inventories. Machine Sales 3mth rolling: World -5%, NA -4%, APAC -5%, LATAM -12%.\n\n**Chevron Corp. (CVX)** Q4 19 (USD): Loss of 3.51; adj. EPS 1.49 (exp. 1.45), Revenue 35bln (exp. 38.64bln). Included in current quarter were previously announced upstream impairments and write-offs totalling 10.4bln. US upstream segment recorded 8.2bln in impairment charges mainly due to Appalachia Shale and Big Foot. Recognized 1.2bln gain on the sale of its UK Central North Sea assets. Refinery crude oil input rose by 69% to 975k BPD. Cash Flow from operations YTD 27.3bln (prev. 30.6bln). Global production of oil-equivalent was unchanged at 3.08mln BPD. FY20 production growth forecasted to rise by 3%.\n\n**Exxon Mobil Corp. (XOM)** Q4 19 (USD): EPS 1.33, Ex-items 0.41 (exp. 0.43), Revenue 67.17bln (exp. 64.17bln). Production was in line with Q4 '18 at 4mln BPD. Earnings included favourable identified items of about 3.9bln, mainly a gain of 3.7bln from its Norway upstream divestment. Affirms 2020 CapEX guidance.\n\n**International Business Machines (IBM)** named Arvind Krishna as its new CEO, who is currently Senior VP for Cloud and Cognitive software, and was a key figure in the RedHat acquisition.\n\n**Visa Inc. (V)** Q4 19 (USD): Adj. EPS 1.46 (exp. 1.46), Revenue 6.1bln (exp. 6.08bln). Announced 9.5bln share repurchase programme, FY20 revenue growth affirmed at low double digits and EPS growth affirmed in the mid-teens.\u00a0 Payments volume +8%.\n\n\n#NASDAQ 100\n\n\n**Amazon.com Inc. (AMZN)** Q4 19 (USD): EPS 6.47 (exp. 4.04), Revenue 87.4bln (exp. 86.02bln). Q1 revenue view between 69-73bln (exp. 71.65bln), Subscription services sales 5.235bln (exp. 5.16bln), Online store sales 45.657bln (exp. 45.77bln), AWS sales 9.954bln (Exp. 9.84bln), Physical stores 4.365bln (prev. 4.401bln), 150mln prime members around the world, biggest quarterly gain in history. NA sales 53.67bln (prev. 44.124bln), International 23.8bln (exp. 20.83bln). Following the results Morgan Stanley increased its PT to USD 3000.\n\n**Amgen Inc. (AMGN)** Q4 19 (USD): Adj. EPS 3.64 (exp. 3.47), Revenue 6.2bln (exp. 6.06bln). FY20 EPS expected at 14.85-15.60 (exp. 15.98), FY20 revenue expected between 25-25.6bln (exp. 25.3bln). Enbrel sales 1.364bln (exp. 1.828bln), Prolia 752mln (exp. 724mln), Neulasta 665mln (exp. 676mln).\n\n**Charter Communications (CHTR)** Q4 19 (USD): Revenue 11.8bln (exp. 11.73bln). Residential customer relationships +240k (Prev. 207k Y/Y). Total customer relationships increased by 3.8% or 1mln to 27.3mln.\n\n**IDEXX Laboratories (IDXX)** Q4 19 (USD): EPS 1.04 (exp. 0.90), Revenue 0.605bln (exp. 0.6bln). Raised FY20 EPS view to 5.42-5.58 (exp. 5.41), raised FY20 revenue guidance to 2.62-2.66bln (exp. 2.63bln).\n\n**Tesla (TSLA)** plant in Germany could be postponed by 9 months if construction does not start by the middle of March, according to the Brandenburg economy minister.\n\n**Vertex Pharmaceuticals Inc (VRTX)** Q4 19 (USD): EPS 2.23 (exp. 1.20), Revenue 1.41bln (exp. 1.01bln). FY20 product revenue expected between 5.1-5.3bln (exp. 4.87bln).\n\n**Western Digital (WDC)** Q2 19 (USD): EPS 0.62 (exp. 0.58), Revenue 4.2bln (exp. 4.22bln). Q3 Adj. EPS 0.85-1.05 (exp. 0.73), and revenue between 4.1-4.3bln (exp. 4.06bln). Announced it successfully developed its fifth-generation 3D NAND technology, BiCS5.\n\u00a0\n#S&amp;P 500\n\n\n**AbbVie Inc. (ABBV)** received a positive CHMP opinion for its Venclyxto drug , as a chemotherapy free combination regimen for patients with previously untreated chronic lympocytic leukemia. It also received position CHMP opinion for its MAVIRET to shorten once daily treatment for patients with hepatitis C and genotype 3 infection.\n\n**Arthur J. Gallagher &amp; Co. (AJG)** Q4 19 (USD): Adj. EPS 0.58 (exp. 0.52), Revenue 1.68bln (exp. 1.4bln).\n\n**Broadridge Financial Solutions (BR)** Q4 19 (USD): EPS 0.53 (exp. 0.71), Revenue 0.97bln (exp. 1.bln). FY EPS view at lower end of previous guidance.\n\n**Cardinal Health Inc. (CAH)** has initiated field action for company procedure packs which contains gowns that were recalled last week.\n\n**Celanese (CE)** Q4 19 (USD): Adj. EPS 1.99 (exp. 2.13), Revenue 1.43bln (exp. 1.53bln). FY20 EPS view 11.00 (exp. 11.00)\n\n**Church &amp; Dwight (CHD)** Q4 19 (USD): EPS 0.55 (exp. 0.55), Revenue 1.14bln (exp. 1.14bln). Increased dividend to USD 0.24/share, a 5.5% increase. 2020 EPS view 2.64-2.69 (exp. 2.69), revenue growth of 6.5% expected. Q1 EPS view 0.73 (exp. 0.76), revenue view growth of roughly 6.5%.\n\n**Citrix Systems (CTXS)** announced an accelerated USD 1bln share repurchase programme.\n\n**Colgate-Palmolive (CL)** Q4 19 (USD): EPS 0.73 (exp. 0.73), Revenue 4.015bln (exp. 3.93bln). Gross profit margin 60.1% (Prev. 59.1% Y/Y). expects FY20 net sales net growth of 4-6%.\n\n**Eastman Chemical (EMN)** Q4 19 (USD): EPS 1.42 (exp. 1.33), Revenue 1.33 (exp. 2.2bln). FY20 EPS view 7.20-7.60 (exp. 7.74).\n\n**Edwards Lifesciences (EW)** Q4 19 (USD): Adj. EPS 1.46 (exp. 1.49), Revenue 1.2bln (exp. 1.14bln). Raised FY20 EPS view 6.15-6.40 (exp. 6.16, prev. 6.05-6.30), raised FY20 revenue view 4.6-5bln (exp. 4.8bln, prev. 4.5-5bln)\n\n**Honeywell Int'l Inc. (HON)** Q4 19 (USD): EPS 2.06 (exp. 2.04), Revenue 9.496bln (exp. 9.61bln), FY EPS view 8.60-9.00 (exp. 8.14) - sees significant headwinds from 737 Max production delays to aerospace segment this year. Outlook assumes a minimal economic impact for China as well as the Global Economy.\n\n**Illinois Tool Works (ITW)** Q4 19 (USD): EPS 1.89 (exp. 1.85), Revenue 3.5bln (exp. 3.46bln). Plans to repurchase USD 2bln of its shares in 2020. FY20 EPS view 7.65-8.05 (exp. 7.98).\n\n**Johnson Controls International (JCI)** Q4 19 (USD): EPS 0.40 (exp. 0.38), Revenue 5.60bln (exp. 5.57bln)\n\n**LyondellBasell (LYB)** Q4 19 (USD): EPS 1.83 (exp. 2.25), Revenue 8.18bln (exp. 8.44bln). Expects typical seasonal improvements.\n\n**Marathon Petroleum (MPC)** is reportedly mulling the sale of its speedway unit, alongside an IPO.\n\n**Phillips 66 (PSX)** Q4 19 (USD): EPS 1.54 (exp. 1.63), Revenue (exp. 28.07bln).\n\n**ResMed (RMD)** Q4 19 (USD): Adj. EPS 1.21 (exp. 1.02), Revenue 0.736bln (exp. .73bln). Announced it is to acquire SnapWorx, a private software company.\n\n**Robert Half International (RHI)** Q4 19 (USD): EPS 0.98 (exp. 0.98), Revenue 1.54bln (exp. 1.54bln). Q1 EPS view 0.90-0.96 (exp. 3.92), FY Revenue view 1.51-1.58bln (exp. 6.08bln).\u00a0\u00a0\u00a0\u00a0\n\n#OTHER\n\n**Booz Allen Hamilton Holding Corp (BAH)** \nQ3 19 (USD): Adj. EPS 0.80 (exp. 0.76), Revenue 1.8bln (exp. 1.82bln). Raised FY20 EPS view to 3.05-3.15 (exp. 3.15, prev. 3.00-3.10), raised FY Revenue growth view to 10-11.5% (prev. 9-11%).\n\n**Cypress Semiconductor Corp (CY)** Q4 19 (USD): EPS 0.28 (exp. 0.29), Revenue 0.56bln (exp. .56bln).\n\n**Deckers Outdoor Corp (DECK)** Q4 19 (USD): EPS 7.14 (exp. 6.55), Revenue 0.94bln (exp. .0.90bln). Raised FY20 EPS view to 9.40-9.50 (exp. 9.20, prev. 8.90-9.05), FY Revenue view raised to 2.15bln-2.16bln (exp. 2.14bln, prev. 2.115-2.14bln).\n\n**Dropbox (DBX)** announced Olivia Nottebohm as its new COO, Nottebohm is a former executive at **Google (GOOG)** and was Vice President of Google Cloud, SMB Sales and GTM operations.\n\n**Embraer (ERJ)** signed a contract with **SkyWest (SKYW)** for an order of 20 E175 jets for USD 972mln, according to list prices\n\n**KKR &amp; Co Inc (KKR)**  Q4 19 (USD): EPS 0.44 (exp. 0.42), Revenue 0.96bln (exp. .94bln).\n\n**Levi Strauss &amp; Co (LEVI)** Q4 19 (USD): Adj. EPS 0.26 (exp. 0.21), Revenue 1.57bln (exp. 1.58bln). Announced a USD 100mln share repurchase programme, Gross margin +110bps, FY20 EPS view 1.18-1.22 (exp. 1.17).\n\n**Match (MTCH) / The Meet Group (MEET)** dating apps, including Tinder and Bumble, are reportedly under investigation for allowing minors and sex offenders on the applications, according to AP.\n\n**Navistar (NAV)** \u2013 **Volkswagen (VOW3 GY)** truck unit, Traton, confirmed it is planning an offer to purchase the remaining shares of Navistar which it does not currently own for USD 35/shr in cash.\n\n**Nokia (NOK) and Orange (ORAN FP)** announced Nokia will provide a variety of products and services to parts of France, with items ranging from Single Radio Access Network, advanced automation tools as part of its 5G portfolio.\n\n**Phillips 66 Partners LP (PSXP)** Q4 19 (USD): EPS 1.06 (exp. 0.96), Revenue 0.43bln (exp. .42bln).\n\n**United States Steel Corp. (X)** Q4 19 (USD): EPS -0.64 (exp. -1.11), Revenue 2.82bln (exp. 3.56bln). Cut its dividend to 0.05 (prev. 0.06), expects Q1 to be trough for the year due to seasonal factors of its mining operations.\n\n**WWE (WWE)** announced its CFO and co-Presidents Barris and Wilson will be leaving the company and will no longer remain on the board of directors.\n\n\n#Additional US Equity Stories\n\n **(WWE)** downgraded to Equal Weight from Overweight at Morgan Stanley\n\n**Weyerhaeuser (WY)** Q4 19 (USD): Ex-items 0.03 (exp. 0.05), revenue 1.55bln (1.53bln). Sees Q1 Timberlands earnings adj. EBITDA slightly above Q4\u2019s.\n\n**Pfizer (PFE)** announced it received a positive CHMP recommendation for its Tuxience drug, a biosimilar for rheumatoid arthritis.\u00a0\n\n**UPS (UPS)** announced it will be providing over 2mln masks to China in wake of the coronavirus for free, along with other protective gear.", "created_utc": 1580481911, "permalink": "/r/wallstreetbets/comments/ewpfo5/heres_ya_coffee/", "is_self": true}